Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 21-Jun-21 4:16 PM View:  | Anika Therapeutics Inc. (ANIK) | 16-Jun-21 | Grant | 4,172 | -- | -- | 52% 7.95K to 12.13K | |
| 14-May-21 10:00 PM View: | Anika Therapeutics Inc. (ANIK) | 12-May-21 | Market Sale | 2,000 | $42.60 | $85,200.00 | (20%) 9.95K to 7.95K | (3%) |
| 12-Nov-20 4:08 PM View: | Anika Therapeutics Inc. (ANIK) | 10-Nov-20 | Market Sale | 3,446 | $36.77 | $126,709.00 | (26%) 13.4K to 9.95K | (20%) |
| 27-Feb-20 6:54 PM View: | Anika Therapeutics Inc. (ANIK) | 26-Feb-20 | Market Sale | 2,700 | $42.68 | $115,236.00 | (17%) 16.1K to 13.4K | (3%) |
| 27-Feb-20 6:54 PM View: | Anika Therapeutics Inc. (ANIK) | 25-Feb-20 | Grant | 4,107 | -- | -- | 34% 11.99K to 16.1K | |
| 30-Jul-19 4:06 PM View: | Anika Therapeutics Inc. (ANIK) | 29-Jul-19 | Market Sale (Planned) | 3,000 | $55.44 | $166,320.00 | (20%) 14.99K to 11.99K | 20% |
| 28-Feb-19 4:34 PM View: | Anika Therapeutics Inc. (ANIK) | 26-Feb-19 | Grant | 3,842 | -- | -- | 25% 15.15K to 18.99K | |
| 28-Feb-19 4:34 PM View: | Anika Therapeutics Inc. (ANIK) | 26-Feb-19 | Market Sale | 4,000 | $33.06 | $132,240.00 | (21%) 18.99K to 14.99K | (34%) |
| 26-Jan-18 4:08 PM View: | Anika Therapeutics Inc. (ANIK) | 24-Jan-18 | Grant | 1,626 | -- | -- | 12% 13.52K to 15.15K | |
| 16-Aug-17 1:32 PM View: | BioAmber Inc. (BIOA) | 15-Aug-17 | Purchase | 40,000 | -- | -- | 400% 10.0K to 50.0K | |
| 16-Aug-17 1:37 PM View: | BioAmber Inc. (BIOA) | 15-Aug-17 | Purchase | 13,333 | -- | -- | 889% 1.5K to 14.83K | |
| 24-Feb-17 4:05 PM View: | Anika Therapeutics Inc. (ANIK) | 22-Feb-17 | Market Sale | 2,635 | $49.08 | $129,326.00 | (16%) 16.16K to 13.52K | 10% |
| 31-Jan-17 4:08 PM View: | Anika Therapeutics Inc. (ANIK) | 27-Jan-17 | Grant | 1,994 | -- | -- | 14% 14.16K to 16.16K | |
| 29-Feb-16 4:06 PM View: | Anika Therapeutics Inc. (ANIK) | 25-Feb-16 | Market Sale | 2,695 | $43.62 | $117,556.00 | (16%) 16.86K to 14.16K | (1%) |
| 08-Feb-16 4:09 PM View: | Anika Therapeutics Inc. (ANIK) | 04-Feb-16 | Grant | 2,361 | -- | -- | 16% 14.5K to 16.86K | |
| 10-Aug-15 5:18 PM View: | BioAmber Inc. (BIOA) | 10-Aug-15 | Market Purchase | 1,500 | $6.71 | $10,066.00 | 100% 0 to 1.5K | |
| 03-Aug-15 4:07 PM View: | Anika Therapeutics Inc. (ANIK) | 31-Jul-15 | Market Option Sale | 850 | $37.76 | $32,096.00 | (5%) 15.52K to 14.67K | (17%) |
| 03-Aug-15 4:07 PM View: | Anika Therapeutics Inc. (ANIK) | 31-Jul-15 | Market Sale | 168 | $37.76 | $6,343.68 | (1%) 14.67K to 14.5K | (17%) |
| 03-Aug-15 4:07 PM View: | Anika Therapeutics Inc. (ANIK) | 30-Jul-15 | Payment of Exercise | 522 | $36.51 | $19,058.20 | (3%) 16.73K to 16.21K | (21%) |
| 03-Aug-15 4:07 PM View: | Anika Therapeutics Inc. (ANIK) | 30-Jul-15 | Option Exercise | 1,540 | $12.36 | $19,034.40 | 10% 15.19K to 16.73K | |
| 03-Aug-15 4:07 PM View: | Anika Therapeutics Inc. (ANIK) | 30-Jul-15 | Market Option Sale | 690 | $37.39 | $25,799.10 | (4%) 16.21K to 15.52K | (18%) |
| 02-Mar-15 6:56 PM View: | Anika Therapeutics Inc. (ANIK) | 27-Feb-15 | Market Option Sale | 4,621 | $39.49 | $182,483.00 | (23%) 19.81K to 15.19K | (12%) |
| 02-Mar-15 6:56 PM View: | Anika Therapeutics Inc. (ANIK) | 26-Feb-15 | Payment of Exercise | 1,649 | $39.96 | $65,894.00 | (8%) 21.46K to 19.81K | (11%) |
| 02-Mar-15 6:56 PM View: | Anika Therapeutics Inc. (ANIK) | 26-Feb-15 | Option Exercise | 6,270 | $10.50 | $65,852.70 | 41% 15.19K to 21.46K | |
| 05-Feb-15 5:05 PM View: | Anika Therapeutics Inc. (ANIK) | 03-Feb-15 | Grant | 1,511 | -- | -- | 11% 13.68K to 15.19K | |
| 03-Mar-14 4:05 PM View: | Anika Therapeutics Inc. (ANIK) | 27-Feb-14 | Market Sale | 8,914 | $43.47 | $387,492.00 | (39%) 22.59K to 13.68K | (2%) |
| 30-Jan-14 7:23 AM View: | Anika Therapeutics Inc. (ANIK) | 27-Jan-14 | Grant | 1,873 | -- | -- | 9% 20.72K to 22.59K | |
| 13-Mar-13 5:14 PM View: | Anika Therapeutics Inc. (ANIK) | 12-Mar-13 | Market Sale | 2,200 | $14.00 | $30,800.00 | (10%) 22.92K to 20.72K | (215%) |
| 31-Jan-13 1:46 PM View: | Anika Therapeutics Inc. (ANIK) | 29-Jan-13 | Grant | 2,760 | -- | -- | 14% 20.16K to 22.92K | |
| 20-Mar-12 5:35 PM View: | Anika Therapeutics Inc. (ANIK) | 19-Mar-12 | Market Sale | 2,500 | $12.00 | $30,007.50 | (11%) 22.66K to 20.16K | (268%) |
| 03-Feb-12 3:04 PM View: | Anika Therapeutics Inc. (ANIK) | 25-Jan-12 | Grant | 3,296 | -- | -- | 17% 19.36K to 22.66K | |
| 20-Jan-11 4:05 PM View: | Anika Therapeutics Inc. (ANIK) | 18-Jan-11 | Grant | 4,297 | -- | -- | 29% 15.07K to 19.36K | |
| 28-Jan-10 3:55 PM View: | Anika Therapeutics Inc. (ANIK) | 26-Jan-10 | Grant | 4,716 | -- | -- | 46% 10.35K to 15.07K | |
| 03-Mar-09 7:25 PM View: | Anika Therapeutics Inc. (ANIK) | 02-Mar-09 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 03-Mar-09 7:25 PM View: | Anika Therapeutics Inc. (ANIK) | 02-Mar-09 | Option Exercise | 2,850 | -- | -- | 38% 7.5K to 10.35K | |
| 25-Nov-08 4:19 PM View: | Clarient, Inc. (CLRT) | 24-Nov-08 | Market Purchase | 10,000 | $0.93 | $9,291.00 | 49% 20.5K to 30.5K | 172% |
| 22-Sep-08 10:03 AM View: | Clarient, Inc. (CLRT) | 18-Sep-08 | Market Purchase | 5,000 | $1.90 | $9,524.00 | 32% 15.5K to 20.5K | 32% |
| 20-Aug-08 4:06 PM View: | Clarient, Inc. (CLRT) | 12-Aug-08 | Market Purchase | 15,500 | $2.13 | $33,051.00 | 100% 0 to 15.5K | 18% |
| 18-Jun-07 8:46 AM View: | Safeguard Scientifics, Inc. (SFE) | 15-Jun-07 | Market Purchase | 26,100 | $2.68 | $69,886.00 | 100% 0 to 26.1K | 109% |
| 21-Nov-05 3:29 PM View: | Orchid Cellmark Inc. (ORCH) | 18-Nov-05 | Market Purchase | 1,500 | $6.43 | $9,645.00 | 100% 0 to 1.5K | (85%) |
| 22-Apr-05 2:17 PM View: | Genencor International Inc (GCOR) | 20-Apr-05 | Disposition (change in control) | 12,151 | $19.25 | $233,907.00 | (96%) 12.71K to 0.56K | |
| 22-Apr-05 2:17 PM View: | Genencor International Inc (GCOR) | 20-Apr-05 | Disposition (change in control) | 560 | $19.25 | $10,780.00 | (100%) 0.56K to 0 | |
| 16-Sep-03 10:00 PM View: | Genencor International Inc (GCOR) | 15-Sep-03 | Option Exercise | 4,000 | $10.77 | $43,080.00 | 31% 12.71K to 16.71K | |
| 16-Sep-03 10:00 PM View: | Genencor International Inc (GCOR) | 15-Sep-03 | Planned Option Sale | 4,000 | $16.82 | $67,260.00 | (24%) 16.71K to 12.71K | |
| 15-Sep-03 10:00 PM View: | Genencor International Inc (GCOR) | 12-Sep-03 | Option Exercise | 5,000 | $10.77 | $53,850.00 | 39% 12.71K to 17.71K | |
| 15-Sep-03 10:00 PM View: | Genencor International Inc (GCOR) | 12-Sep-03 | Planned Option Sale | 5,000 | $16.48 | $82,380.00 | (28%) 17.71K to 12.71K | |
| 15-Sep-03 10:00 PM View: | Genencor International Inc (GCOR) | 11-Sep-03 | Option Exercise | 5,000 | $10.77 | $53,850.00 | 39% 12.71K to 17.71K | |
| 15-Sep-03 10:00 PM View: | Genencor International Inc (GCOR) | 11-Sep-03 | Planned Option Sale | 5,000 | $16.12 | $80,612.00 | (28%) 17.71K to 12.71K | |
| 11-Sep-03 10:00 PM View: | Genencor International Inc (GCOR) | 10-Sep-03 | Option Exercise | 5,000 | $10.77 | $53,850.00 | 39% 12.71K to 17.71K | |
| 11-Sep-03 10:00 PM View: | Genencor International Inc (GCOR) | 10-Sep-03 | Planned Option Sale | 5,000 | $16.17 | $80,825.50 | (28%) 17.71K to 12.71K |